Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 6,850.00
+640.00 (10.31%)
May 21, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 75.74 billion as of May 20, 2026. Its market cap has decreased by -58.39% in one year.
Market Cap
75.74B
Enterprise Value
57.66B
Revenue
370.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,850.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 75.74B, a decrease of -28.72%. That is a compound annual growth rate of -21.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 75.74B | -34.27% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 152.21B |
| Vaxcell-Bio Therapeutics | 145.59B |
| MedPacto | 144.30B |
| ENCell | 130.59B |
| Amicogen | 120.26B |
| iNtRON Biotechnology | 97.53B |
| GeneOne Life Science | 95.30B |
| Prestige BioPharma | 90.63B |